Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Sposto

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
Cancer Immunology, Immunotherapy : CII|August 29, 2013
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1Yibing Xu, Jianping Sun, Michael A Sheard, et al.
British Journal of Haematology|March 29, 2008
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international studyMary Gerrard, Mitchell S Cairo, Claire Weston, et al.
International Journal of Cancer|April 18, 2018
Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytesMatthew W Webb, Jianping Sun, Michael A Sheard, et al.
Pediatric Blood & Cancer|July 16, 2015
Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupKathleen A Meeske, Lingyun Ji, David R Freyer, et al.
The Journal of Clinical Investigation|August 22, 2007
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastomaLiping Song, Tasnim Ara, Hong-Wei Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer CellsHong-Wei Wu, Michael A Sheard, Jemily Malvar, et al.
Annals of Surgical Oncology|January 10, 2012
Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imagingStephanie A Valente, Gary M Levine, Melvin J Silverstein, et al.
Cancer Research|July 9, 2017
Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal CellsLucia Borriello, Rie Nakata, Michael A Sheard, et al.
Blood|July 9, 2009
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425Cindy L Schwartz, Louis S Constine, Doojduen Villaluna, et al.
The New England Journal of Medicine|February 8, 2002
Expression of p53 and prognosis in children with malignant gliomasIan F Pollack, Sydney D Finkelstein, Jeffrey Woods, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
Cancer Immunology, Immunotherapy : CII|August 29, 2013
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1Yibing Xu, Jianping Sun, Michael A Sheard, et al.
British Journal of Haematology|March 29, 2008
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international studyMary Gerrard, Mitchell S Cairo, Claire Weston, et al.
International Journal of Cancer|April 18, 2018
Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytesMatthew W Webb, Jianping Sun, Michael A Sheard, et al.
Pediatric Blood & Cancer|July 16, 2015
Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupKathleen A Meeske, Lingyun Ji, David R Freyer, et al.
The Journal of Clinical Investigation|August 22, 2007
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastomaLiping Song, Tasnim Ara, Hong-Wei Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer CellsHong-Wei Wu, Michael A Sheard, Jemily Malvar, et al.
Annals of Surgical Oncology|January 10, 2012
Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imagingStephanie A Valente, Gary M Levine, Melvin J Silverstein, et al.
Cancer Research|July 9, 2017
Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal CellsLucia Borriello, Rie Nakata, Michael A Sheard, et al.
Blood|July 9, 2009
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425Cindy L Schwartz, Louis S Constine, Doojduen Villaluna, et al.
The New England Journal of Medicine|February 8, 2002
Expression of p53 and prognosis in children with malignant gliomasIan F Pollack, Sydney D Finkelstein, Jeffrey Woods, et al.
Pageof 18